172 related articles for article (PubMed ID: 12694308)
1. Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease.
Annuk M; Zilmer M; Fellström B
Kidney Int Suppl; 2003 May; (84):S50-3. PubMed ID: 12694308
[TBL] [Abstract][Full Text] [Related]
2. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension.
Okubo K; Hayashi K; Wakino S; Matsuda H; Kubota E; Honda M; Tokuyama H; Yamamoto T; Kajiya F; Saruta T
Hypertens Res; 2005 Feb; 28(2):181-9. PubMed ID: 16025746
[TBL] [Abstract][Full Text] [Related]
3. Chronic renal failure: oxidative stress, endothelial dysfunction and wine.
Caimi G; Carollo C; Lo Presti R
Clin Nephrol; 2004 Nov; 62(5):331-5. PubMed ID: 15571176
[TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction in individuals born after fetal growth restriction: cardiovascular and renal consequences and preventive approaches.
Yzydorczyk C; Armengaud JB; Peyter AC; Chehade H; Cachat F; Juvet C; Siddeek B; Simoncini S; Sabatier F; Dignat-George F; Mitanchez D; Simeoni U
J Dev Orig Health Dis; 2017 Aug; 8(4):448-464. PubMed ID: 28460648
[TBL] [Abstract][Full Text] [Related]
5. [Asymmetric dimethylarginine--a novel cardiovascular risk factor].
Siroká R; Cibulka R; Rajdl D; Racek J
Vnitr Lek; 2006 Mar; 52(3):249-55. PubMed ID: 16722156
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and endothelial function in chronic renal failure.
Annuk M; Zilmer M; Lind L; Linde T; Fellström B
J Am Soc Nephrol; 2001 Dec; 12(12):2747-2752. PubMed ID: 11729244
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
8. Endothelial function, CRP and oxidative stress in chronic kidney disease.
Annuk M; Soveri I; Zilmer M; Lind L; Hulthe J; Fellström B
J Nephrol; 2005; 18(6):721-6. PubMed ID: 16358230
[TBL] [Abstract][Full Text] [Related]
9. Endothelial function and oxidative stress in cardiovascular diseases.
Higashi Y; Noma K; Yoshizumi M; Kihara Y
Circ J; 2009 Mar; 73(3):411-8. PubMed ID: 19194043
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in patients with cardiovascular disease and chronic renal failure.
Popolo A; Autore G; Pinto A; Marzocco S
Free Radic Res; 2013 May; 47(5):346-56. PubMed ID: 23438723
[TBL] [Abstract][Full Text] [Related]
11. The vascular endothelium in chronic renal failure.
Morris ST; Jardine AG
J Nephrol; 2000; 13(2):96-105. PubMed ID: 10858970
[TBL] [Abstract][Full Text] [Related]
12. Impaired endothelial function in isolated human uremic resistance arteries.
Morris ST; McMurray JJ; Spiers A; Jardine AG
Kidney Int; 2001 Sep; 60(3):1077-82. PubMed ID: 11532102
[TBL] [Abstract][Full Text] [Related]
13. Impairment of vascular responses to reactive hyperemia and nitric oxide in chronic renal failure.
Nakanishi T; Ishigami Y; Otaki Y; Izumi M; Hiraoka K; Inoue T; Takamitsu Y
Nephron; 2002; 92(3):529-35. PubMed ID: 12372934
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
Tatematsu S; Wakino S; Kanda T; Homma K; Yoshioka K; Hasegawa K; Sugano N; Kimoto M; Saruta T; Hayashi K
J Am Soc Nephrol; 2007 Mar; 18(3):741-9. PubMed ID: 17267746
[TBL] [Abstract][Full Text] [Related]
15. Association of asymmetric dimethylarginine and endothelial dysfunction.
Böger RH
Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
[TBL] [Abstract][Full Text] [Related]
16. Asymmetrical dimethylarginine plasma concentrations are related to basal nitric oxide release but not endothelium-dependent vasodilation of resistance arteries in peritoneal dialysis patients.
Mittermayer F; Schaller G; Pleiner J; Vychytil A; Sunder-Plassmann G; Hörl WH; Wolzt M
J Am Soc Nephrol; 2005 Jun; 16(6):1832-8. PubMed ID: 15857920
[TBL] [Abstract][Full Text] [Related]
17. Endothelial dysfunction and chronic kidney disease: treatment options.
Wu-Wong JR
Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
[TBL] [Abstract][Full Text] [Related]
18. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
Yilmaz MI; Saglam M; Caglar K; Cakir E; Sonmez A; Ozgurtas T; Aydin A; Eyileten T; Ozcan O; Acikel C; Tasar M; Genctoy G; Erbil K; Vural A; Zoccali C
Am J Kidney Dis; 2006 Jan; 47(1):42-50. PubMed ID: 16377384
[TBL] [Abstract][Full Text] [Related]
19. Effect of different intensities of exercise on endothelium-dependent vasodilation in humans: role of endothelium-dependent nitric oxide and oxidative stress.
Goto C; Higashi Y; Kimura M; Noma K; Hara K; Nakagawa K; Kawamura M; Chayama K; Yoshizumi M; Nara I
Circulation; 2003 Aug; 108(5):530-5. PubMed ID: 12874192
[TBL] [Abstract][Full Text] [Related]
20. Carbamylated low-density lipoprotein induces endothelial dysfunction.
Speer T; Owala FO; Holy EW; Zewinger S; Frenzel FL; Stähli BE; Razavi M; Triem S; Cvija H; Rohrer L; Seiler S; Heine GH; Jankowski V; Jankowski J; Camici GG; Akhmedov A; Fliser D; Lüscher TF; Tanner FC
Eur Heart J; 2014 Nov; 35(43):3021-32. PubMed ID: 24658767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
